Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial
Andrology · 2026-08-14
DOI: 10.1111/andr.70348 ↗At a glance
Journal article in Andrology, published online on 2026-08-14. Written by Bu B Yeap and 11 co-authors. Institution: Medical School, University of Western Australia, Perth, Australia. 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council, University of Adelaide, Weight Watchers and Sonic Healthcare.
Abstract (original language)
Background
Lower testosterone concentrations in older men are associated with poorer health outcomes.
Objective
We examined whether, on a background of lifestyle intervention, testosterone treatment modulates leucocyte telomere length, a postulated marker of biological ageing, in overweight men with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D). Participants and Methods We conducted a secondary analysis of a randomised, placebo‐controlled trial in 50‐ to 74‐year‐old men with waist circumference ≥ 95 cm and dysglycaemia (ACTRN12612000287831). All men received a background lifestyle program, and were randomised to 2 years treatment with intramuscular testosterone undecanoate (1000 mg) every 3 months or placebo. Leucocyte telomere length was assayed by multiplex quantitative polymerase chain reaction and expressed as relative telomere length (rTL), a ratio of telomeric DNA to β‐globin, a single‐copy control gene (T/S ratio).
Results
There were 720 participants, aged 60 ± 6 years (mean ± SD), 38% had BMI 30–34.99 kg/m 2 and 44% ≥ 35 kg/m 2 . Mean rTL at baseline was 1.63 ± 0.27 in testosterone‐treated men ( N = 375) and 1.61 ± 0.28 in placebo‐treated men ( N = 345). At 2 years, mean rTL was 1.61 ± 0.28 and 1.58 ± 0.29, respectively. Change in rTL after 2 years treatment was −0.02 ± 0.15 in testosterone‐treated and −0.03 ± 0.12 in placebo‐treated men. Adjusting for baseline values there was no effect of testosterone treatment on rTL at 2 years (mean difference 0.01 [95% CI, −0.01 to 0.03], p = 0.24). Results were similar for rTL change at 2 years from baseline.
Conclusions
There was no effect of testosterone treatment on telomere length in this group of men. Larger studies with longer treatment durations are merited.
Subjects
Author keywords
Authors and institutions
- Medical School, University of Western Australia, Perth, Australia.
- Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Australia.
- PathWest Laboratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
- School of Population and Global Health, University of Western Australia, Perth, Australia.
- NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
- Department of Medicine (Austin Health), University of Melbourne, Melbourne, Australia.
ORCID profiles: Bu B Yeap, Jennie Hui, Kristy P Robledo, Gillian Arscott, Mathis Grossmann, David J Handelsman, Warrick J Inder, Bronwyn G A Stuckey, Alicia J Jenkins, Karen Bracken, Gary A Wittert
Funding
- National Health and Medical Research Council
- University of Adelaide
- Weight Watchers and Sonic Healthcare
- Bayer
- Lilly
- Eli Lilly and Company
Cite
APA
Yeap, B. B., Hui, J., Robledo, K. P., Arscott, G., Grossmann, M., Handelsman, D. J., Inder, W. J., Stuckey, B. G. A., Jenkins, A. J., Bracken, K., Beilby, J. P., & Wittert, G. A. (2026). Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial. Andrology. https://doi.org/10.1111/andr.70348
Vancouver
Yeap BB, Hui J, Robledo KP, Arscott G, Grossmann M, Handelsman DJ, et al. Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial. Andrology. 2026. doi:10.1111/andr.70348
BibTeX
@article{Yeap2026,
author = {Yeap, Bu B and Hui, Jennie and Robledo, Kristy P and Arscott, Gillian and Grossmann, Mathis and Handelsman, David J and Inder, Warrick J and Stuckey, Bronwyn G A and Jenkins, Alicia J and Bracken, Karen and Beilby, John P and Wittert, Gary A},
title = {Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial},
journal = {Andrology},
year = {2026},
doi = {10.1111/andr.70348}
}
EUVIMED